Healthcare News
The many ways that AI enters rheumatology
Artificial intelligence (AI) is entering the mainstream. The term encompasses a wide variety of machines that can learn from data, identify patterns, and make decisions. But how can it be used to support health care? EULAR—The European Alliance of Associations for Rheumatology—has picked a number of abstracts for its 2025 congress in Barcelona that showcase how AI is influencing different areas in rheumatology—from diagnosis through to monitoring, risk prediction, and patient communication.
Patients with knee osteoarthritis who receive metformin exhibit improved pain
Patients with knee osteoarthritis who received metformin demonstrated significant reductions in knee pain and increased weight loss at 6 months vs. placebo, according to data published in JAMA.
EULAR updates recommendations for antirheumatic drugs in pregnancy, breastfeeding
Antimalarials, azathioprine, colchicine, cyclosporine, sulfasalazine and tacrolimus are compatible with pregnancy, while the use of NSAIDs and steroids should be “more restrictive,” according to updated EULAR recommendations.
Skin disease history may guide best treatment options for systemic lupus
Patients with systemic lupus erythematosus with a history of cutaneous lupus erythematosus are more likely to have high interferon levels, despite a cessation of skin manifestations, according to a study.
Dubious therapies in rheumatic disease: Treatments for sale vs. treatments for free
It provides an excellent opportunity to explore the diverse therapies available to help our patients suffering from rheumatic diseases — ranging from rigorously evidence-based treatments to modalities supported by little or no evidence.
